GCT Takes Part at ISCTM

September was full of events for the pharma and biotech community.

GCT President, Dr. Jeffrey Apter, participated at the annual Autumn conference organized by the International Society for CNS Clinical Trials and Methology (ISCTM).

From 21 to 25 of September professionals all over the world took part virtually in the #ISCTM2020.  The topics addressing clinical, regulatory, methodological and policy challenges in CNS clinical trials were among the many discussed.

GCT is a global CRO focused on CNS and Neurology clinical trials, and on the market since 2001. Dr. Jeffrey Apter, GCT president is the Key Opinion Leader in psychiatry specializing in Alzheimer’s disease and Depression research. Should you have any questions or require information about clinical trials, please contact us at bd@gctrials.com

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.